PI3K mediates the ability of insulin growth factor to activate the Eag channel, and the ability of serum to activate the intermediate-conductance Ca2+-activated K+ channel in breast carcinoma and lymphoma cells, respectively [54],[55]. The gene discussed is INS; the disease is breast carcinoma.